High-efficiency transfection of cultured primary motor neurons to study protein localization, trafficking, and function.
BACKGROUND
Cultured spinal motor neurons are a valuable tool to study basic mechanisms of development, axon growth and pathfinding, and, importantly, to analyze the pathomechanisms underlying motor neuron diseases. However, the application of this cell culture model is limited by the lack of efficient gene transfer techniques which are available for other neurons. To address this problem, we have established magnetofection as a novel method for the simple and efficient transfection of mouse embryonic motor neurons. This technique allows for the study of the effects of gene expression and silencing on the development and survival of motor neurons.


RESULTS
We found that magnetofection, a novel transfection technology based on the delivery of DNA-coated magnetic nanobeads, can be used to transfect primary motor neurons. Therefore, in order to use this method as a new tool for studying the localization and transport of axonal proteins, we optimized conditions and determined parameters for efficient transfection rates of >45% while minimizing toxic effects on survival and morphology. To demonstrate the potential of this method, we have used transfection with plasmids encoding fluorescent fusion-proteins to show for the first time that the spinal muscular atrophy-disease protein Smn is actively transported along axons of live primary motor neurons, supporting an axon-specific role for Smn that is different from its canonical function in mRNA splicing. We were also able to show the suitability of magnetofection for gene knockdown with shRNA-based constructs by significantly reducing Smn levels in both cell bodies and axons, opening new opportunities for the study of the function of axonal proteins in motor neurons.


CONCLUSIONS
In this study we have established an optimized magnetofection protocol as a novel transfection method for primary motor neurons that is simple, efficient and non-toxic. We anticipate that this novel approach will have a broad applicability in the study of motor neuron development, axonal trafficking, and molecular mechanisms of motor neuron diseases.
Fallini
Claudia
C
Department of Cell Biology, Emory University School of Medicine, Atlanta 30322, USA. wrossol@emory.edu.
Bassell
Gary J
GJ
Rossoll
Wilfried
W
Nat Protoc. 2007;2(12):3090-101
18079708
J Cell Biol. 2003 Nov 24;163(4):801-12
14623865
Stem Cells Dev. 2008 Feb;17(1):133-41
18271700
Curr Opin Cell Biol. 2009 Jun;21(3):387-93
19286363
J Neurosci. 2003 Jul 23;23(16):6627-37
12878704
Results Probl Cell Differ. 2009;48:289-326
19343312
Science. 2002 May 3;296(5569):913-6
11988576
J Neurol. 2000 Mar;247 Suppl 1:I37-42
10795885
Methods Mol Biol. 2009;487:111-46
19301645
Nat Methods. 2008 Jul;5(7):605-7
18536722
J Gene Med. 2004 Aug;6(8):923-36
15293351
Mol Cell Neurosci. 1996 Mar;7(3):239-46
8726106
Nat Rev Neurosci. 2009 Aug;10(8):597-609
19584893
Nat Rev Genet. 2009 Nov;10(11):769-82
19823194
Semin Pediatr Neurol. 2006 Jun;13(2):121-31
17027862
Expert Opin Biol Ther. 2003 Aug;3(5):745-58
12880375
Neuron. 2005 Dec 22;48(6):885-96
16364894
Amyotroph Lateral Scler Other Motor Neuron Disord. 2001 Mar;2 Suppl 1:S55-68
11465926
Science. 2008 Apr 25;320(5875):524-7
18440926
Histochem Cell Biol. 2007 Apr;127(4):439-48
17102992
J Cell Biol. 2003 Sep 1;162(5):919-31
12952942
Biochemistry. 2007 May 22;46(20):5904-10
17444659
Nat Biotechnol. 2004 Dec;22(12):1567-72
15558047
Hum Gene Ther. 1996 Jun 10;7(9):1131-8
8773515
Nat Protoc. 2007;2(7):1692-704
17641634
J Neurosci Res. 1999 Jan 1;55(1):119-26
9890440
J Cell Biol. 1999 Oct 4;147(1):59-70
10508855
J Neurochem. 2000 May;74(5):1820-8
10800924
J Neurosci Res. 1999 Dec 15;58(6):831-5
10583914
Bioessays. 2005 Sep;27(9):946-57
16108074
Cell Tissue Res. 2000 Jul;301(1):71-84
10928282
Methods. 2004 Jun;33(2):95-103
15121163